XBiotech XBIT Cash Flow Statement (2014-2026)

NASDAQ XBIT
$2.02 +0.02 (+1.00%)
As of: Oct 20, 2026 · 1:41 PM EDT
Reported Financials

XBiotech Quarterly Cash Flow Statement

Periods 49 quarters
Latest Jun 2026

XBiotech cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 49 quarters of results from Mar 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income
-5.12M-3.26M-6.47M-5.40M-11.64M-12.66M-3.20M-3.82M-8.74M-7.36M-4.64M-10.00M-13.01M-5.02M-10.51M-10.88M-1.76M-6.01M-26.89M-6.73M
Depreciation and DepletionDep. & Depletion
0.64M0.69M0.70M0.71M0.73M0.73M0.44M0.44M0.44M0.43M0.39M0.43M0.44M0.44M0.44M0.44M0.44M0.43M0.38M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.64M0.69M0.70M0.71M0.73M0.73M0.44M0.44M0.44M0.43M0.39M0.43M0.44M0.44M0.44M0.44M0.44M0.43M0.38M
Share-based CompensationStock Comp.
1.04M1.13M1.35M1.45M1.45M1.13M1.04M0.71M0.91M0.96M0.69M0.38M0.38M0.37M0.63M3.33M0.11M0.02M0.16M0.17M
Deferred Taxes
0.98M-0.42M-0.35M-0.04M-0.06M
Change in Working Capital
Change in ReceivablesChange Receivables
-1.66M0.02M-0.04M0.50M-0.50M1.53M-1.53M
Change in Account PayablesChange Payables
0.38M-0.65M1.17M-0.81M1.03M-0.96M1.10M-1.06M0.44M-0.32M1.03M0.01M-0.83M-0.20M0.65M-1.13M0.33M-0.39M0.49M
Change in Accured ExpensesChange Accured Exp.
0.34M-0.04M-0.27M0.19M4.02M-3.60M-0.39M0.60M0.43M1.03M-0.17M0.69M1.15M-0.86M-1.86M1.67M-1.89M0.01M3.90M
Change in TaxesChange Taxes
-4.76M-2.29M1.44M-1.07M-2.40M11.25M0.78M0.02M-0.05M0.20M0.30M0.03M0.03M-0.12M-0.02M0.03M0.03M0.10M0.08M
Change in Other Operating AssetsOther Assets Change
-2.70M-0.55M0.02M-0.30M-0.09M0.08M-0.02M0.10M0.24M-0.07M-0.12M0.31M0.04M-0.07M-0.01M0.12M0.16M-0.25M-0.02M
Change in Other Operating LiabilitiesOther Liabilities Change
Other Working Capital ChangesOther WC Changes
2.70M0.55M-0.02M0.30M0.09M-0.08M0.02M-0.10M-0.24M0.07M0.12M-0.31M-0.04M0.07M0.01M-0.12M-0.16M0.25M0.02M
Cash from OperationsCash from Ops.
72.80M-3.40M-1.76M-5.12M-5.39M-1.15M-3.16M-4.81M-9.00M-1.49M-3.43M-7.20M-11.38M-5.85M-6.54M-6.72M-5.99M-4.26M-22.95M
Investing Activities
Capital ExpendituresCapex
1.71M0.70M0.48M0.16M0.08M0.21M0.13M0.01M0.21M0.03M0.12M0.26M0.63M0.34M0.08M0.09M0.05M0.11M0.03M
Change in Property, Plant and EquipmentChange in PP&E
-1.71M-0.70M-0.48M-0.16M-0.08M-0.21M-0.13M-0.01M-0.21M-0.03M-0.12M-0.26M-0.63M-0.34M-0.08M-0.09M-0.05M-0.11M-0.03M
Purchase of InvestmentsInvestments Purchased
3.78M
Cash from Investing ActivitiesCash from Investing
-1.71M-0.70M-0.48M-0.16M-0.08M-59.74M-3.91M-0.01M-0.21M61.83M-0.12M-0.26M-0.63M-0.34M-0.08M-0.09M-0.05M-0.11M-0.03M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
10.00M0.25M-10.00M-0.25M
Non-Current Debt
10.00M0.25M-10.00M-0.25M
Net Debt Issuances and RepaymentsNet Debt Issuance
10.00M0.25M-10.00M-0.25M
Change in Capital Stock
Common Stock IssuedStock Issued
3.98M2.96M0.03M0.01M0.06M0.05M0.06M0.03M
Net Shares Issued and RepurchasedNet Shares Issued
3.98M2.96M0.03M0.01M0.06M0.05M0.06M0.03M
Net Equity Issued and RepurchasedNet Equity Issued
3.98M2.96M0.03M0.01M0.06M0.05M0.06M0.03M
Other financing activitiesOther financing
Cash from Financing ActivitiesCash from Financing
3.98M-72.04M0.03M-0.01M0.01M10.06M0.05M0.06M0.28M-10.25M
Additional items
Exchange Rate EffectFX Effect
0.32M-0.24M0.31M0.12M-0.56M-4.33M3.81M-0.01M0.13M-1.54M1.38M-1.58M-0.55M3.57M-6.96M0.28M3.08M-1.20M1.17M
Change in Cash
75.38M-76.38M-1.89M-5.16M-6.03M-65.23M-3.26M-4.82M-9.09M58.80M-2.17M1.02M-12.51M-5.41M-10.44M-16.78M-2.96M-5.57M-21.82M
Ending Cash Balance
315.26M238.88M236.98M231.82M225.79M160.57M157.31M152.48M143.39M202.19M200.02M201.04M188.53M183.12M172.68M155.90M152.94M147.37M125.55M109.53M
Free Cash FlowFCF
71.09M-4.10M-2.24M-5.28M-5.47M-1.36M-3.30M-4.81M-9.21M-1.52M-3.55M-7.46M-12.00M-6.18M-6.62M-6.81M-6.04M-4.37M-22.99M
Net Cash FlowNCF
75.06M-76.14M-2.20M-5.28M-5.47M-60.89M-7.07M-4.81M-9.22M60.34M-3.55M2.60M-11.96M-6.12M-6.34M-17.06M-6.04M-4.37M-22.99M
Interest Paid
0.40M-0.40M0.40M0.49M

XBiotech Cash Flow Statement API

Pull XBiotech's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=XBIT&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY